InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

C4 Therapeutics, Inc.

CCCC Clue Score37
United States Fiscal year ends December CIK 0001662579 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Adam Crystal
4 Jan 2022
Chief Medical Officer
Sold after exercise
1,054
$32.66
$34.42K
Adam Crystal
4 Jan 2022
Chief Medical Officer
Sold after exercise
13,946
$31.59
$440.55K
Adam Crystal
1 Oct 2021
Chief Medical Officer
Sold after exercise
5,112
$45.99
$235.12K
Adam Crystal
1 Oct 2021
Chief Medical Officer
Sold after exercise
8,176
$45.32
$370.56K
Adam Crystal
1 Oct 2021
Chief Medical Officer
Sold after exercise
1,712
$44.25
$75.76K
Jolie Siegel
10 Sep 2021
Chief Legal Officer
Sold after exercise
12,500
$50.00
$625.00K
Adam Crystal
29 Jul 2021
Chief Medical Officer
Sold after exercise
15,000
$45.00
$675.00K
Jolie Siegel
29 Jul 2021
Chief Legal Officer
Sold after exercise
12,500
$45.00
$562.50K
Adam Crystal
1 Jul 2021
Chief Medical Officer
Sold after exercise
1,700
$38.38
$65.25K
Adam Crystal
1 Jul 2021
Chief Medical Officer
Sold after exercise
13,300
$37.93
$504.42K
Adam Crystal
5 Apr 2021
Chief Medical Officer
Sold after exercise
10,879
$38.00
$413.41K
Adam Crystal
5 Apr 2021
Chief Medical Officer
Sold after exercise
4,121
$37.16
$153.13K
Show all 85 transactions →

What was left out

Form 4 filings counted 260
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 12
Sales at will 40
Transactions with no price 0
Shares from compensation/vesting 14,138,520
Sales filed before the plan box existed 39
History held since 5 Oct 2020